Pharmaceuticals

Medical Device Clinical Trials Market Forecast With Insights On Demand And Industry Growth

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Medical Device Clinical Trials Market Between 2026 And 2030?

The medical device clinical trials market size has experienced robust expansion in recent years. It is projected to increase from $18.07 billion in 2025 to $19.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. This historical growth can be attributed to several factors, including heightened medical device innovation, rigorous regulatory approval mandates, an increasing need for patient safety validation, the broadening of hospital-based clinical research activities, and greater investment in generating clinical evidence.

The medical device clinical trials market size is projected to experience robust growth in the coming years. This market is anticipated to reach $25.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This projected expansion stems from factors such as the growth of wearable and connected medical devices, heightened regulatory scrutiny concerning device performance, the broadening of digital trial platforms, increased uptake of remote patient monitoring within trials, and the growing globalization of clinical studies. Key trends anticipated include a greater embrace of decentralized clinical trials, the expanding application of real-world evidence in device trials, an elevated emphasis on post-approval and long-term safety studies, the spread of adaptive and hybrid trial designs, and an escalating need for regulatory-compliant trial management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

What Key Factors Are Affecting The Medical Device Clinical Trials Market Demand?

The increasing prevalence of chronic diseases is projected to drive the expansion of the medical device clinical trials market moving forward. Chronic diseases are long-term health issues that advance gradually and necessitate ongoing medical care. The rise in these conditions is attributed to sedentary lifestyles, where individuals spend extended periods seated or using electronic devices, leading to reduced calorie expenditure and compromised cardiovascular health, which contributes to issues such as obesity, diabetes, and hypertension. This growth in chronic diseases generates a need for medical device clinical trials to develop and validate novel devices for effective diagnosis, treatment, and management. As an illustration, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes, a number projected to more than double to 1.3 billion people by 2050. Thus, the escalating incidence of chronic diseases is fueling the growth of the medical device clinical trials market.

How Are Different Segments Classified In The Medical Device Clinical Trials Market Segment Analysis?

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

What Trends Are Influencing The Medical Device Clinical Trials Market?

Major companies operating in the medical device clinical trials market are increasingly focusing on developing AI-powered medical device software. This strategy aims to optimize clinical trial protocols and resource allocation, thereby enhancing trial efficiency and reducing overall costs. AI-powered medical device software refers to applications within healthcare that employ artificial intelligence (AI) algorithms, especially machine learning or deep learning, to either support or automate medical tasks. For instance, in January 2025, Risklick, a Switzerland-based pharmaceutical company, launched Protocol AI. This AI-based software is specifically designed to accelerate and optimize clinical trials for medical devices. Protocol AI leverages Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, enabling it to automatically draft clinical trial protocols in minutes. This innovation significantly reduces the time and cost typically required for protocol development, a process that conventionally takes about six months, and has already demonstrated up to a 50% reduction in document development time for medicinal products.

Who Are The Companies Driving Activity In The Medical Device Clinical Trials Market?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

Get The Full Medical Device Clinical Trials Market Report:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

Which Region Represents The Largest Share Of The Medical Device Clinical Trials Market?

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Medical Device Clinical Trials Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

Browse Through More Reports Similar to the Global Medical Device Clinical Trials Market 2026, By The Business Research Company

Clinical Trial Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Medical Device Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795